Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T17066 |
Umbralisib hydrochloride
RP5264 hydrochloride,TGR-1202 hydrochloride |
PI3K | PI3K/Akt/mTOR signaling |
Umbralisib hydrochloride is a novel PI3Kδ inhibitor (IC50 and EC50 of 22.2 nM and 24.3 nM, respectively). Umbralisib hydrochloride is also active against CK1ε (EC50: 6.0 μM). | |||
T4976 |
Umbralisib
TGR-1202,RP5264,TGR 1202,TGR1202 |
PI3K | PI3K/Akt/mTOR signaling |
Umbralisib (TGR 1202) 是一种PI3Kδ抑制剂,IC50=22.2 nM,EC50=24.3 nM。它同时可抑制CK1ε,EC50=6.0 μM。 | |||
T72527 |
Umbralisib sulfate
TGR-1202 sulfate ; RP-5264 sulfate,TGR-1202 sulfate,RP-5264 sulfate |
||
Umbralisib (TGR-1202) sulfate 是一种口服有效、选择性的 PI3Kδ和 酪蛋白激酶-1-ε (CK1ε) 双抑制剂,其 EC50分别为 22.2 nM 和 6.0 μM。 Umbralisib sulfate 显示出对慢性淋巴细胞白血病 (CLL) T 细胞独特的免疫调节作用。Umbralisib sulfate 可用于血液系统恶性肿瘤的研究。 | |||
T13140 |
Umbralisib R-enantiomer
TGR-1202 R-enantiomer,RP5264 R-enantiomer |
PI3K | PI3K/Akt/mTOR signaling |
Umbralisib R-enantiomer (RP5264 R-enantiomer) 是 PI3K 的δ型抑制剂,是 TGR-1202 活性较低的对映体。Umbralisib R-enantiomer 对δ型 pi3激酶的 IC50,至少比抑制剂对其他 PI3K 亚型(A, β和γ)的 IC50低20倍。 |